Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

Status unconfirmed · Phase 4

Conditions studied: Reversible Pulpitis, Dental Pulp Diseases

In brief

Mineral trioxide aggregate has been previously FDA approved as an endodontic filler. Its use in vital teeth has demonstrated significant color change post-treatment leaving it ineffective for esthetic use.. The new formulation will be tested to see if has the same effect.

Key facts

Study ID: NCT02702505
Run by: Texas A & M University Baylor College Of Dentistry
People needed: 50
Starts: 2014-11-01
Expected to finish: 2017-12-01
Last updated by the study team: 2016-03-08

Who can join

Age: 2 and older, up to 8. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children between the ages of 2 ½ and 8 years of age
Patient must have two, contralateral primary molars that are matched for type of molar (first or second), size of carious lesion (same level of approximation of carious lesion to the pulp), and arch (maxillary or mandibular) that are treatment planned for a pulpotomy
The teeth selected for the study must be vital and asymptomatic both clinically and radiographically or only display symptoms consistent with reversible pulptitis
The teeth selected for the study must be anticipated to be retained in the mouth for at least two years
Each patient must have an updated medical history form in the dental record, be examined by the operator, and be classified as ASA I or II (in good general health)

You may not qualify if…

Teeth with a history of spontaneous pain
Teeth with radiographic evidence of internal or external resorption, intraradicular or periapical bone loss, loss of lamina dura, or widening of the periodontal ligament space

Where it is running

Texas A & M University Baylor College of Dentistry — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.